Perhaps to maintain a more prolonged period of drug activity. Even if dose is lower - patients will get more coverage this way.  Given what we know about the half-life of this drug - a two times a week administration won't create a steady-state from dose to dose. They must have some info that suggests likelihood of improved response with biweeekly regimen.